🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 día
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/02/1998 55,58 56,18 55,28 56,03 +1,46% 1,61% 6.192.213
09/02/1998 54,75 55,22 54,12 55,22 +1,31% 2,02% 4.062.467
06/02/1998 54,09 55,16 53,94 54,51 +0,88% 2,26% 5.407.261
05/02/1998 55,22 55,28 53,67 54,03 -1,52% 2,92% 5.604.914
04/02/1998 54,99 55,13 54,63 54,87 -1,08% 0,92% 4.089.506
03/02/1998 55,94 55,94 54,57 55,46 -1,27% 2,45% 7.522.334
02/02/1998 57,25 57,34 56,18 56,18 +0,32% 2,03% 7.056.603
30/01/1998 56,06 56,12 55,64 56,00 -0,42% 0,85% 4.463.642
29/01/1998 56,06 56,77 55,73 56,24 +0,21% 1,86% 6.800.891
28/01/1998 55,11 56,57 55,02 56,12 +2,73% 2,81% 8.948.034
27/01/1998 54,09 55,58 53,97 54,63 +0,44% 2,98% 8.033.549
26/01/1998 54,39 54,84 54,21 54,39 +0,94% 1,15% 4.305.813
23/01/1998 54,21 54,27 52,99 53,88 +0,28% 2,37% 5.152.387
22/01/1998 53,91 54,69 53,70 53,73 -1,21% 1,83% 4.983.869
21/01/1998 54,63 55,02 53,44 54,39 -1,30% 2,89% 6.989.531
20/01/1998 52,78 55,34 52,72 55,11 +5,24% 4,97% 10.955.373
16/01/1998 52,21 52,78 51,88 52,36 +0,98% 1,71% 7.687.290
15/01/1998 52,12 52,24 51,82 51,85 -1,08% 0,80% 6.655.010
14/01/1998 50,81 52,48 50,69 52,42 +3,41% 3,52% 10.690.438
13/01/1998 50,69 51,02 50,57 50,69 +0,06% 0,88% 6.517.931
12/01/1998 48,66 50,75 48,37 50,66 +3,22% 4,90% 8.138.139
09/01/1998 50,51 50,63 48,96 49,08 -3,12% 3,31% 6.614.347
08/01/1998 49,92 51,02 49,83 50,66 +1,01% 2,39% 5.134.362
07/01/1998 50,45 50,57 49,53 50,16 -1,52% 2,07% 6.228.264
06/01/1998 50,78 51,47 50,75 50,93 -1,39% 1,41% 5.057.438
05/01/1998 51,35 51,94 50,84 51,65 +0,58% 2,15% 6.298.480
02/01/1998 50,21 51,44 50,07 51,35 +1,53% 2,73% 4.791.666
31/12/1997 50,81 51,02 50,04 50,57 -0,64% 1,94% 2.844.691
30/12/1997 50,10 51,05 50,01 50,90 +1,85% 2,08% 3.103.966
29/12/1997 49,74 50,18 49,65 49,98 +1,21% 1,08% 3.537.000